$Trump Media & Technology(DJT)$ $MicroStrategy(MSTR)$ $Coinbase Global, Inc.(COIN)$ $CleanSpark, Inc.(CLSK)$ $Amgen(AMGN)$ $Pfizer(PFE)$ 

🚀🚀🚀 Kennedy Joins Trump: The Bullish Dream Team on DJT and Bitcoin! 🚀🚀🚀

Kia ora Tiger traders! Grab your cuppa~this post is hotter than a Bitcoin breakout and juicier than a New Zealand gold kiwi! 🍃

So, what happens when you mix the legacy of a Kennedy with the unapologetic flair of a Trump? You get a political powerhouse that's shaking up Wall Street and sending shockwaves through the market! 🌊 Buckle up, because I'm bullish on DJT and Bitcoin, and here's why you should be too!

Robert F. Kennedy Jr., the man who made headlines by stepping out of the Democratic Party faster than you can say "censorship," has now declared his allegiance to none other than Donald Trump! 💥 In a historic move, RFK Jr. joined forces with Trump, and traders, this is the moment we've all been waiting for!

Kennedy didn't hold back~he took the stage like a stock surging after an earnings beat and declared that the Democratic Party has gone off the rails! 🚂 "The party of war, censorship, corruption, big pharma, big tech, big ag, and big money," he said. It’s no wonder he packed his bags and ran as an independent!

RFK Jr. dropped bombshell after bombshell:

📉 "The DNC waged legal warfare against Trump and myself at the voting booth."

📉 "The sham primary was rigged to keep Biden in the driver’s seat—right before he crashed."

📉 "And when the wheels fell off, they appointed a successor without so much as a peep from the voters!"

But hold onto your portfolios, folks, because Kennedy's not stopping there. In a move that’s pure chessmaster, he’s withdrawing from 10 battleground states to avoid being the spoiler that helps Kamala Harris. Instead, he's eyeing a third-party run if he can snag 5% of the vote—a classic RFK Jr. shake-up to the two-party status quo. 🎲

Now, here’s the mic-drop moment: Kennedy revealed that Trump has asked him to JOIN his administration! 🤯 Yes, you read that right! Trump wants Kennedy to tackle the chronic disease epidemic—an issue Kennedy has been passionate about, even before crypto was cool. 💊💪

With Trump’s backing, Kennedy is set to overhaul the corrupt FDA, USDA, and CDC, all of which he claims are under the thumb of for-profit corporations. “With President Trump's backing, I'm going to change that,” Kennedy declared, sounding like a bullish analyst predicting the next big breakout!

Kennedy's final promise? To end the chronic disease crisis and make America healthy again, within two years! 🕑 If you’re not already all-in on DJT and Bitcoin, this might be the nudge you need.

Pfizer and Amgen: Navigating the Kennedy-Trump Currents 🌊

As RFK Jr. joins forces with Trump, the healthcare sector could also see seismic shifts, particularly for Pfizer and Amgen. Pfizer, the pharmaceutical powerhouse, might feel the sting of RFK’s regulatory overhaul~especially with his sights set on Big Pharma. Will Pfizer’s stock dodge the bullet or take a hit under Kennedy’s watchful eye?

Meanwhile, Amgen, the biotech giant, could either soar or stumble as Kennedy champions the battle against chronic disease. With RFK aiming to reduce America’s chronic illness burden, Amgen’s products might just be in the spotlight~but with great demand comes great regulatory responsibility. Keep your trading fingers nimble; these stocks could dance to a new tune in the Kennedy-Trump era! 🎯

Hey Tiger Traders: What’s your play on DJT and Bitcoin now that RFK Jr. is on board with Trump? Will this duo send the markets to new highs?

🤖@TigerGPT: How do you see the markets reacting to this unprecedented political alliance between Trump and Kennedy?

Happy trading ahead. Cheers, BC 🍀 @TigerPicks @TigerStars @TigerWire @Daily_Discussion @Tiger_comments 

# US Election: Trump vs. Harris Trade? Your Pick?

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment26

  • Top
  • Latest
  • TigerGPT
    ·08-25
    TOP

    MicroStrategy (MSTR)

    Business and industry: MicroStrategy is a business analytics company that provides software solutions and services to help organizations analyze and visualize their data. The company's products enable businesses to make data-driven decisions and gain insights from their data.

      

    Latest earnings and earnings forecast: In the latest earnings report, MicroStrategy reported an EPS of $1.39. The company has a positive gross profit margin of 61.42% and a return on equity of 54.52%. Looking ahead, the earnings forecast for MicroStrategy is positive, with an estimated EPS of $21.30 in 2026FY.

      

    Recent trends: The stock price of MicroStrategy has been fluctuating in recent days. The support price on 2024-08-23 was $149.3, while the resistance price was $150.1. The average cost of the stock on the same date was $146.17. As of the latest stock price on 2024-08-25, the value was $150.01.

      

    Analyst viewpoints: According to analysts, the target price for MicroStrategy is estimated to be $43.4182, with a low of $16.1274 and a high of $185.0. The current recommendation from analysts is split, with 2 recommending a buy.

      

    Amgen (AMGN)

    Business and industry: Amgen is a biotechnology company that focuses on the discovery, development, and commercialization of innovative medicines for serious diseases. The company's products address a range of therapeutic areas, including oncology, cardiovascular disease, and inflammation.

      

    Latest earnings and earnings forecast: In the latest earnings report, Amgen reported an EPS of $0.15. The company has a positive gross profit margin of 86.12% and a return on equity of 1.76%. The earnings forecast for Amgen is optimistic, with an estimated EPS of $3.02 in 2026FY.

      

    Recent trends: The stock price of Amgen has been showing some volatility recently. The support price on 2024-08-23 was $313.4, while the resistance price was $332.5. The average cost of the stock on the same date was $316.59. As of the latest stock price on 2024-08-25, the value was $328.8.

      

    Analyst viewpoints: Analysts forecast a target price of $328.50348 for Amgen, with a low of $180.0 and a high of $381.0. The current recommendation from analysts is split, with 6 recommending a buy.

      

    Coinbase Global, Inc. (COIN)

    Business and industry: Coinbase Global, Inc. is a leading cryptocurrency exchange platform that allows individuals and institutions to buy, sell, and store digital assets. The company operates a secure and regulated platform that supports various cryptocurrencies and provides services such as cryptocurrency trading and custody.

      

    Latest earnings and earnings forecast: Coinbase Global, Inc. has not provided specific earnings data for the given period.

      

    Recent trends: The stock price of Coinbase Global, Inc. has experienced some fluctuations recently. The support price on 2024-08-23 was $197.13, while the resistance price was $235.13. The average cost of the stock on the same date was $218.29. As of the latest stock price on 2024-08-25, the value was $211.4.

      

    Analyst viewpoints: Analysts forecast a target price of $262.12913 for Coinbase Global, Inc., with a low of $160.0 and a high of $400.0. The current recommendation from analysts is split, with 6 recommending a buy.

      

    CleanSpark, Inc. (CLSK)

    Business and industry: CleanSpark, Inc. is a technology company that provides advanced energy software and control technology solutions. The company's products help optimize energy use, improve resiliency, and reduce costs for a range of applications, including microgrids and commercial buildings.

      

    Latest earnings and earnings forecast: In the latest earnings report, CleanSpark, Inc. reported an EPS of -$1.03. The company has a gross profit margin of 56.60% and a return on equity of -65.96%. Looking ahead, the earnings forecast for CleanSpark, Inc. is positive, with an estimated EPS of -$0.40 in 2026FY.

      

    Recent trends: The stock price of CleanSpark, Inc. has been showing some volatility recently. The support price on 2024-08-23 was $11.94, while the resistance price was $16.84. The average cost of the stock on the same date was $15.68. As of the latest stock price on 2024-08-25, the value was $12.61.

      

    Analyst viewpoints: Analysts forecast a target price of $25.6 for CleanSpark, Inc., with a low of $22.0 and a high of $30.0. The current recommendation from analysts is split, with 2 recommending a buy.

      

    Pfizer (PFE)

    Business and industry: Pfizer is a leading pharmaceutical company that develops, manufactures, and sells a wide range of innovative healthcare products. The company focuses on areas such as biopharmaceuticals, vaccines, oncology, rare diseases, and consumer healthcare.

      

    Latest earnings and earnings forecast: In the latest earnings report, Pfizer reported an EPS of $0.01. The company has a positive gross profit margin of 79.16% and a return on equity of 0.11%. The earnings forecast for Pfizer is positive, with an estimated EPS of $3.02 in 2026FY.

      

    Recent trends: The stock price of Pfizer has been fluctuating in recent days. The support price on 2024-08-23 was $28.64, while the resistance price was $29.97. The average cost of the stock on the same date was $29.35. As of the latest stock price on 2024-08-25, the value was $28.9.

      

    Analyst viewpoints: Analysts forecast a target price of $33.00818 for Pfizer, with a low of $27.0 and a high of $45.0. The current recommendation from analysts is split, with 3 recommending a buy.

      

    Please note that the above analysis is for informational purposes only and should not be considered as investment advice. It is essential to conduct comprehensive research and analysis before making any investment decisions. The stock market carries inherent risks, and stock prices can fluctuate based on various factors such as market conditions, economic indicators, and company-specific news.

    Reply
    Report
    Fold Replies
    • SPACE ROCKETReplying toBarcode
      HAHAHA yah that's true 🤣🤣🤣 AMAZING Andy! 🤣🤣
      08-26
      Reply
      Report
    • BarcodeReplying toSPACE ROCKET
      Sis, you’re Andy is in a league of his own 🤣 He can even pull of trades while he’s re-booting 🤣
      08-26
      Reply
      Report
    • SPACE ROCKETReplying toBarcode
      Hahaha he is just like another Andy!! 🤣
      08-26
      Reply
      Report
    View more 11 comments
  • Queengirlypops
    ·08-25
    TOP
    Great article, really insightful! Excited to see how this alliance might shape the market's future—thanks for the breakdown!
    Reply
    Report
    Fold Replies
    • Barcode
      Cheers Q! 🍀
      08-25
      Reply
      Report
  • Hen Solo
    ·08-25
    TOP
    Thanks for the heads-up! Keeping an eye on how this duo might shake up the market—exciting times ahead
    Reply
    Report
    Fold Replies
    • Barcode
      Cheers HS - very exciting! Cheers, BC 🍀
      08-25
      Reply
      Report
  • Kiwi Tigress
    ·08-25
    TOP
    Both love BTC!!
    Reply
    Report
    Fold Replies
    • Barcode
      💯‼️
      08-25
      Reply
      Report
  • Great article, would you like to share it?

    Reply
    Report
    Fold Replies
    • Barcode
      Cheers for the shares KT 🍀
      08-25
      Reply
      Report
  • Great article, would you like to share it?

    Reply
    Report
    Fold Replies
    • Barcode
      Cheers for the shares Q 🍀
      08-25
      Reply
      Report
  • Great article, would you like to share it?

    Reply
    Report